Suppliers / Boryung Pharmaceutical

Boryung Pharmaceutical

South Korea Updated 9 July 2026

Boryung Pharmaceutical is an API and finished-dose manufacturer based in South Korea. It holds one valid CEP. Its filings concentrate with DIGEMAPS (DO), JFDA (JO) and NPRA (MY).

0
active US DMFs
1
valid CEPs
1
registered plants
23
filings across 5 regulators

Registered plants

Site FDA FEI
Seoul, South Korea Not on file

What they file, and where

Molecule Regulators Docs
Doxorubicin Hydrochloride EDQM 1

Also appears on these molecule pages

Doxorubicin API Epirubicin finished dose

Filings and GMP by regulator

Regulator Filings GMP certificates
DIGEMAPS (DO) 7 None
JFDA (JO) 6 None
NPRA (MY) 5 None
MINSA (CR) 4 None
ARCSA (EC) 1 None

Questions about Boryung Pharmaceutical

Does Boryung Pharmaceutical hold a US DMF or a CEP?
Boryung Pharmaceutical holds 1 valid CEP. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Boryung Pharmaceutical manufacture?
1 registered site is on record, in South Korea (Seoul). Every site is listed on this page with the register it came from.
What does Boryung Pharmaceutical make?
1 molecule is on record against Boryung Pharmaceutical, including Doxorubicin Hydrochloride. Each links through to that molecule's full manufacturer list.
Where does Boryung Pharmaceutical file?
Filings are on record with DIGEMAPS (DO), JFDA (JO), NPRA (MY), MINSA (CR) and 1 other regulator, 23 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Boryung Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Olon shares 1 molecule Hisun Pharmaceutical shares 1 molecule Dzd (Heze) Pharmaceutical shares 1 molecule Synbias Pharma shares 1 molecule MicroBiopharm Japan shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability